Molecular pathways: linking tumor microenvironment to epithelial-mesenchymal transition in metastasis
During tumor development, tumor cells constantly communicate with the surrounding microenvironment through both biochemical and biophysical cues. In particular, the tumor microenvironment can instruct carcinoma cells to undergo a morphogenesis program termed epithelial-to-mesenchymal transition (EMT...
Gespeichert in:
Veröffentlicht in: | Clinical cancer research 2015-03, Vol.21 (5), p.962-968 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 968 |
---|---|
container_issue | 5 |
container_start_page | 962 |
container_title | Clinical cancer research |
container_volume | 21 |
creator | Jung, Hae-Yun Fattet, Laurent Yang, Jing |
description | During tumor development, tumor cells constantly communicate with the surrounding microenvironment through both biochemical and biophysical cues. In particular, the tumor microenvironment can instruct carcinoma cells to undergo a morphogenesis program termed epithelial-to-mesenchymal transition (EMT) to facilitate local invasion and metastatic dissemination. Growing evidence uncovered a plethora of microenvironmental factors in promoting EMT, including proinflammatory cytokines secreted by locally activated stromal cells, hypoxia conditions, extracellular matrix components, and mechanical properties. Here, we review various biochemical and biophysical factors in the tumor microenvironment that directly impinge upon the EMT program. Specifically, cytokines such as TGFβ, TNFα, and IL6 and hypoxia are capable of inducing EMT in various tumors. Several extracellular matrix (ECM) proteins, including collagen-I, fibronectin, and hyaluronan, and ECM remodeling via extracellular lysyl oxidase are also implicated in regulating EMT. In preclinical studies and ongoing clinical trials, targeting these tumor microenvironmental signals has shown promises in halting tumor progression in various human cancers. |
doi_str_mv | 10.1158/1078-0432.ccr-13-3173 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4320988</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1660655354</sourcerecordid><originalsourceid>FETCH-LOGICAL-c581t-71e12986ce9765d1f9cda8563a6d1a6512a3b9136dc030304c50f26471beb88e3</originalsourceid><addsrcrecordid>eNpVUV1rFTEQDWKxtfoTlDz6sjWz2WSzPghyUVtoKYg-h9zs3N5oPq5JtuX-e3PpB5YZmIE5c2Y4h5B3wM4AhPoIbFQdG3h_Zm3ugHccRv6CnIAQY8d7KV62_hFzTF6X8psxGIANr8hxL9poAnFC8Cp5tIs3me5M3d6ZfflEvYt_XLyhdQkp0-BsThhvXU4xYKy0Joo7V7fonfFdwILRbvfBeFqzicVVlyJ1kQasprR05Q052hhf8O1DPSW_vn39uTrvLq-_X6y-XHZWKKjdCAj9pKTFaZRihs1kZ6OE5EbOYKSA3vD1BFzOlvEWgxVs08thhDWulUJ-Sj7f8-6WdcDZtm-z8XqXXTB5r5Nx-vkkuq2-Sbe6acQmpRrBhweCnP4uWKoOrlj03kRMS9EgJZNCcDE0qLiHNnVKybh5OgNMHyzSB_n1QX69Wv3QwPXBorb3_v8fn7YePeH_ADB_kKs</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1660655354</pqid></control><display><type>article</type><title>Molecular pathways: linking tumor microenvironment to epithelial-mesenchymal transition in metastasis</title><source>MEDLINE</source><source>American Association for Cancer Research</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Jung, Hae-Yun ; Fattet, Laurent ; Yang, Jing</creator><creatorcontrib>Jung, Hae-Yun ; Fattet, Laurent ; Yang, Jing</creatorcontrib><description>During tumor development, tumor cells constantly communicate with the surrounding microenvironment through both biochemical and biophysical cues. In particular, the tumor microenvironment can instruct carcinoma cells to undergo a morphogenesis program termed epithelial-to-mesenchymal transition (EMT) to facilitate local invasion and metastatic dissemination. Growing evidence uncovered a plethora of microenvironmental factors in promoting EMT, including proinflammatory cytokines secreted by locally activated stromal cells, hypoxia conditions, extracellular matrix components, and mechanical properties. Here, we review various biochemical and biophysical factors in the tumor microenvironment that directly impinge upon the EMT program. Specifically, cytokines such as TGFβ, TNFα, and IL6 and hypoxia are capable of inducing EMT in various tumors. Several extracellular matrix (ECM) proteins, including collagen-I, fibronectin, and hyaluronan, and ECM remodeling via extracellular lysyl oxidase are also implicated in regulating EMT. In preclinical studies and ongoing clinical trials, targeting these tumor microenvironmental signals has shown promises in halting tumor progression in various human cancers.</description><identifier>ISSN: 1078-0432</identifier><identifier>EISSN: 1557-3265</identifier><identifier>DOI: 10.1158/1078-0432.ccr-13-3173</identifier><identifier>PMID: 25107915</identifier><language>eng</language><publisher>United States</publisher><subject>Animals ; Antineoplastic Agents - pharmacology ; Antineoplastic Agents - therapeutic use ; Clinical Trials as Topic ; Cytokines - genetics ; Cytokines - metabolism ; Epithelial-Mesenchymal Transition - drug effects ; Epithelial-Mesenchymal Transition - genetics ; Extracellular Matrix Proteins - genetics ; Extracellular Matrix Proteins - metabolism ; Humans ; Hypoxia - genetics ; Hypoxia - metabolism ; Molecular Targeted Therapy ; Neoplasm Metastasis ; Neoplasms - drug therapy ; Neoplasms - genetics ; Neoplasms - metabolism ; Neoplasms - pathology ; Signal Transduction - drug effects ; Translational Medical Research ; Treatment Outcome ; Tumor Microenvironment - drug effects ; Tumor Microenvironment - genetics</subject><ispartof>Clinical cancer research, 2015-03, Vol.21 (5), p.962-968</ispartof><rights>2014 American Association for Cancer Research.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c581t-71e12986ce9765d1f9cda8563a6d1a6512a3b9136dc030304c50f26471beb88e3</citedby><cites>FETCH-LOGICAL-c581t-71e12986ce9765d1f9cda8563a6d1a6512a3b9136dc030304c50f26471beb88e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,315,781,785,886,3357,27926,27927</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25107915$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jung, Hae-Yun</creatorcontrib><creatorcontrib>Fattet, Laurent</creatorcontrib><creatorcontrib>Yang, Jing</creatorcontrib><title>Molecular pathways: linking tumor microenvironment to epithelial-mesenchymal transition in metastasis</title><title>Clinical cancer research</title><addtitle>Clin Cancer Res</addtitle><description>During tumor development, tumor cells constantly communicate with the surrounding microenvironment through both biochemical and biophysical cues. In particular, the tumor microenvironment can instruct carcinoma cells to undergo a morphogenesis program termed epithelial-to-mesenchymal transition (EMT) to facilitate local invasion and metastatic dissemination. Growing evidence uncovered a plethora of microenvironmental factors in promoting EMT, including proinflammatory cytokines secreted by locally activated stromal cells, hypoxia conditions, extracellular matrix components, and mechanical properties. Here, we review various biochemical and biophysical factors in the tumor microenvironment that directly impinge upon the EMT program. Specifically, cytokines such as TGFβ, TNFα, and IL6 and hypoxia are capable of inducing EMT in various tumors. Several extracellular matrix (ECM) proteins, including collagen-I, fibronectin, and hyaluronan, and ECM remodeling via extracellular lysyl oxidase are also implicated in regulating EMT. In preclinical studies and ongoing clinical trials, targeting these tumor microenvironmental signals has shown promises in halting tumor progression in various human cancers.</description><subject>Animals</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Clinical Trials as Topic</subject><subject>Cytokines - genetics</subject><subject>Cytokines - metabolism</subject><subject>Epithelial-Mesenchymal Transition - drug effects</subject><subject>Epithelial-Mesenchymal Transition - genetics</subject><subject>Extracellular Matrix Proteins - genetics</subject><subject>Extracellular Matrix Proteins - metabolism</subject><subject>Humans</subject><subject>Hypoxia - genetics</subject><subject>Hypoxia - metabolism</subject><subject>Molecular Targeted Therapy</subject><subject>Neoplasm Metastasis</subject><subject>Neoplasms - drug therapy</subject><subject>Neoplasms - genetics</subject><subject>Neoplasms - metabolism</subject><subject>Neoplasms - pathology</subject><subject>Signal Transduction - drug effects</subject><subject>Translational Medical Research</subject><subject>Treatment Outcome</subject><subject>Tumor Microenvironment - drug effects</subject><subject>Tumor Microenvironment - genetics</subject><issn>1078-0432</issn><issn>1557-3265</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVUV1rFTEQDWKxtfoTlDz6sjWz2WSzPghyUVtoKYg-h9zs3N5oPq5JtuX-e3PpB5YZmIE5c2Y4h5B3wM4AhPoIbFQdG3h_Zm3ugHccRv6CnIAQY8d7KV62_hFzTF6X8psxGIANr8hxL9poAnFC8Cp5tIs3me5M3d6ZfflEvYt_XLyhdQkp0-BsThhvXU4xYKy0Joo7V7fonfFdwILRbvfBeFqzicVVlyJ1kQasprR05Q052hhf8O1DPSW_vn39uTrvLq-_X6y-XHZWKKjdCAj9pKTFaZRihs1kZ6OE5EbOYKSA3vD1BFzOlvEWgxVs08thhDWulUJ-Sj7f8-6WdcDZtm-z8XqXXTB5r5Nx-vkkuq2-Sbe6acQmpRrBhweCnP4uWKoOrlj03kRMS9EgJZNCcDE0qLiHNnVKybh5OgNMHyzSB_n1QX69Wv3QwPXBorb3_v8fn7YePeH_ADB_kKs</recordid><startdate>20150301</startdate><enddate>20150301</enddate><creator>Jung, Hae-Yun</creator><creator>Fattet, Laurent</creator><creator>Yang, Jing</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20150301</creationdate><title>Molecular pathways: linking tumor microenvironment to epithelial-mesenchymal transition in metastasis</title><author>Jung, Hae-Yun ; Fattet, Laurent ; Yang, Jing</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c581t-71e12986ce9765d1f9cda8563a6d1a6512a3b9136dc030304c50f26471beb88e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Animals</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Clinical Trials as Topic</topic><topic>Cytokines - genetics</topic><topic>Cytokines - metabolism</topic><topic>Epithelial-Mesenchymal Transition - drug effects</topic><topic>Epithelial-Mesenchymal Transition - genetics</topic><topic>Extracellular Matrix Proteins - genetics</topic><topic>Extracellular Matrix Proteins - metabolism</topic><topic>Humans</topic><topic>Hypoxia - genetics</topic><topic>Hypoxia - metabolism</topic><topic>Molecular Targeted Therapy</topic><topic>Neoplasm Metastasis</topic><topic>Neoplasms - drug therapy</topic><topic>Neoplasms - genetics</topic><topic>Neoplasms - metabolism</topic><topic>Neoplasms - pathology</topic><topic>Signal Transduction - drug effects</topic><topic>Translational Medical Research</topic><topic>Treatment Outcome</topic><topic>Tumor Microenvironment - drug effects</topic><topic>Tumor Microenvironment - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jung, Hae-Yun</creatorcontrib><creatorcontrib>Fattet, Laurent</creatorcontrib><creatorcontrib>Yang, Jing</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical cancer research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jung, Hae-Yun</au><au>Fattet, Laurent</au><au>Yang, Jing</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Molecular pathways: linking tumor microenvironment to epithelial-mesenchymal transition in metastasis</atitle><jtitle>Clinical cancer research</jtitle><addtitle>Clin Cancer Res</addtitle><date>2015-03-01</date><risdate>2015</risdate><volume>21</volume><issue>5</issue><spage>962</spage><epage>968</epage><pages>962-968</pages><issn>1078-0432</issn><eissn>1557-3265</eissn><abstract>During tumor development, tumor cells constantly communicate with the surrounding microenvironment through both biochemical and biophysical cues. In particular, the tumor microenvironment can instruct carcinoma cells to undergo a morphogenesis program termed epithelial-to-mesenchymal transition (EMT) to facilitate local invasion and metastatic dissemination. Growing evidence uncovered a plethora of microenvironmental factors in promoting EMT, including proinflammatory cytokines secreted by locally activated stromal cells, hypoxia conditions, extracellular matrix components, and mechanical properties. Here, we review various biochemical and biophysical factors in the tumor microenvironment that directly impinge upon the EMT program. Specifically, cytokines such as TGFβ, TNFα, and IL6 and hypoxia are capable of inducing EMT in various tumors. Several extracellular matrix (ECM) proteins, including collagen-I, fibronectin, and hyaluronan, and ECM remodeling via extracellular lysyl oxidase are also implicated in regulating EMT. In preclinical studies and ongoing clinical trials, targeting these tumor microenvironmental signals has shown promises in halting tumor progression in various human cancers.</abstract><cop>United States</cop><pmid>25107915</pmid><doi>10.1158/1078-0432.ccr-13-3173</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1078-0432 |
ispartof | Clinical cancer research, 2015-03, Vol.21 (5), p.962-968 |
issn | 1078-0432 1557-3265 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4320988 |
source | MEDLINE; American Association for Cancer Research; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
subjects | Animals Antineoplastic Agents - pharmacology Antineoplastic Agents - therapeutic use Clinical Trials as Topic Cytokines - genetics Cytokines - metabolism Epithelial-Mesenchymal Transition - drug effects Epithelial-Mesenchymal Transition - genetics Extracellular Matrix Proteins - genetics Extracellular Matrix Proteins - metabolism Humans Hypoxia - genetics Hypoxia - metabolism Molecular Targeted Therapy Neoplasm Metastasis Neoplasms - drug therapy Neoplasms - genetics Neoplasms - metabolism Neoplasms - pathology Signal Transduction - drug effects Translational Medical Research Treatment Outcome Tumor Microenvironment - drug effects Tumor Microenvironment - genetics |
title | Molecular pathways: linking tumor microenvironment to epithelial-mesenchymal transition in metastasis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T11%3A00%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Molecular%20pathways:%20linking%20tumor%20microenvironment%20to%20epithelial-mesenchymal%20transition%20in%20metastasis&rft.jtitle=Clinical%20cancer%20research&rft.au=Jung,%20Hae-Yun&rft.date=2015-03-01&rft.volume=21&rft.issue=5&rft.spage=962&rft.epage=968&rft.pages=962-968&rft.issn=1078-0432&rft.eissn=1557-3265&rft_id=info:doi/10.1158/1078-0432.ccr-13-3173&rft_dat=%3Cproquest_pubme%3E1660655354%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1660655354&rft_id=info:pmid/25107915&rfr_iscdi=true |